The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program Home
Abstract Details
Activity Number:
|
270
|
Type:
|
Invited
|
Date/Time:
|
Tuesday, July 31, 2012 : 8:30 AM to 10:20 AM
|
Sponsor:
|
Section for Statistical Programmers and Analysts
|
Abstract - #303595 |
Title:
|
Some Limitations of CDISC: SDTM and ADaM as Sponsor Operational Models
|
Author(s):
|
Mario Widel*+ and Henry B. Winsor
|
Companies:
|
Roche Molecular Systems, Inc. and Winsorworks Ltd.
|
Address:
|
4300 Hacienda Drive, Pleasanton, CA, , USA
|
Keywords:
|
CDISC ;
SDTM ;
ADaM ;
NDA ;
PLA ;
Operational Model
|
Abstract:
|
Both SDTM (since 2005) and ADaM (more recently) have demonstrated distinct advantages to FDA reviewers when they receive data in these formats. Both SDTM and ADaM are mentioned in FDA guidance as highly desirable, so more and more sponsors are including SDTM and ADaM as an integral part of the NDA/BLA/PLA submissions.
While some sponsors create and submit these data sets as final products for review, others are trying to use these data sets internally as well as in submissions. While there are distinct advantages to the latter method (fewer steps, a more efficient organization, etc.), there are many challenges that arise and need to be addressed before a sponsor is going to be in a position to successfully use SDTM and ADaM internally.
This paper addresses these challenges and offers a few proposed strategies that can be used to overcome them.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2012 program
|
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.